LIXT Financials 07/16/2014 01:03:22 Lixte Biotech

LIXT Financials 07/16/2014 01:03:22
Lixte Biotechnology, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 880 1,012 1,335 446
Sales, General and Admin. 495 1,094 533 436
Non-Recurring Items - - - -
Other - - - -
Operating Income (1,375) (2,106) (1,868) (882)
Income From Continuing Operations
Add'l Income/Expense Items - (1,474) (200) 1
Earnings Before Interest and Tax (1,375) (3,579) (2,068) (880)
Interest Expense - - - -
Earnings Before Tax (1,375) (3,579) (2,068) (880)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (1,375) (3,579) (2,068) (880)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (1,375) (3,579) (2,068) (880)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (1,375) (3,579) (2,068) (880)